Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025 at 07:47 AM EST
Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.
